You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Suppliers and packagers for POLYETHYLENE GLYCOL 3350


✉ Email this page to a colleague

« Back to Dashboard


POLYETHYLENE GLYCOL 3350

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA ANI Pharmaceuticals, Inc. 62559-157-10 100 PACKET in 1 CARTON (62559-157-10) / 17 g in 1 PACKET (62559-157-17) 2020-03-24
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA ANI Pharmaceuticals, Inc. 62559-157-30 30 PACKET in 1 CARTON (62559-157-30) / 17 g in 1 PACKET (62559-157-17) 2020-03-24
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA SKY Packaging 63739-760-02 14 PACKET in 1 CARTON (63739-760-02) / 17 g in 1 PACKET (63739-760-01) 2024-08-01
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA SKY Packaging 63739-760-04 100 PACKET in 1 CARTON (63739-760-04) / 17 g in 1 PACKET (63739-760-01) 2024-08-01
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA NorthStar Rx LLC 72603-302-02 14 PACKET in 1 CARTON (72603-302-02) / 17 g in 1 PACKET (72603-302-01) 2025-04-01
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA NorthStar Rx LLC 72603-302-03 30 PACKET in 1 CARTON (72603-302-03) / 17 g in 1 PACKET (72603-302-01) 2025-04-01
Ani Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 202850 ANDA NorthStar Rx LLC 72603-302-04 100 PACKET in 1 CARTON (72603-302-04) / 17 g in 1 PACKET (72603-302-01) 2025-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Polyethylene Glycol 3350

Last updated: July 30, 2025

Introduction

Polyethylene glycol 3350 (PEG 3350) is a widely used osmotic laxative primarily employed to treat occasional constipation. Its efficacy and safety profile have led to extensive pharmaceutical use, prompting a robust supply chain comprising numerous manufacturers and suppliers globally. For pharmaceutical companies, healthcare providers, and distributors, understanding the landscape of PEG 3350 suppliers is critical for ensuring consistent quality, regulatory compliance, and cost efficiency.

This article offers a comprehensive overview of the leading suppliers of PEG 3350, analyzing their production capacities, quality standards, and market positions. It aims to guide stakeholders in making informed procurement decisions within the dynamic pharmaceutical supply ecosystem.

Regulatory Background and Market Drivers

PEG 3350 is classified as an excipient and active pharmaceutical ingredient (API), subject to stringent regulatory standards by authorities such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other global agencies. Its manufacturer and supplier compliance with Good Manufacturing Practices (GMP) is critical to ensure quality, safety, and efficacy.

Growing demand driven by aging populations, increased prevalence of gastrointestinal disorders, and expanded OTC product availability underpin a resilient market. The global market for polyethylene glycols (including PEG 3350) is projected to grow steadily, emphasizing the need for reliable, high-quality suppliers.

Key Suppliers of PEG 3350

1. BASF SE

Overview:
BASF, a German chemical giant, is among the leading manufacturers of polyethylene glycol products, including PEG 3350. Their extensive R&D infrastructure and manufacturing facilities enable high-quality production compliant with international standards.

Capabilities and Offerings:

  • Widespread range of PEG molecular weight variants
  • Consistent supply of pharmaceutical-grade PEG 3350
  • Robust quality assurance and GMP-certified manufacturing

Market Position:
BASF’s global footprint and rigorous quality control position it as a preferred supplier for pharmaceutical companies seeking reliable sources. Its extensive portfolio and technical expertise in PEG synthesis make it a dependable partner.

2. Dow Chemical (Dow Inc.)

Overview:
Dow is another prominent name in the polyethylene glycol market, offering a broad portfolio of PEG products, including PEG 3350. Their manufacturing processes are highly regulated, and their products are routinely used in pharmaceutical applications.

Capabilities and Offerings:

  • Pharmaceutical-grade PEG 3350 with high purity levels
  • Customizable molecular weight distributions
  • Extensive distribution network

Market Position:
Dow’s presence in the pharmaceutical excipients market and its reputation for quality make it a significant supplier for multinational pharmaceutical firms.

3. Ashland Global Holdings Inc.

Overview:
Ashland is recognized for its specialty chemicals and excipients portfolio, including PEG 3350 tailored for pharmaceutical applications.

Capabilities and Offerings:

  • GMP-compliant PEG 3350
  • Focus on customer-specific formulations
  • Expertise in excipient EU and FDA approvals

Market Position:
Ashland’s specialization in pharmaceutical excipients and its customer-centric approach facilitate close collaboration with pharmaceutical developers.

4. Sigma-Aldrich (a subsidiary of Merck Group)

Overview:
Sigma-Aldrich supplies lab-grade and pharmaceutical-grade chemicals globally, including PEG 3350 used in formulation and research.

Capabilities and Offerings:

  • High-purity PEG 3350 suitable for pharmaceutical manufacturing
  • Ready availability through global distribution channels
  • Quality control aligned with pharmaceutical standards

Market Position:
While primarily known for research chemicals, Sigma-Aldrich’s pharmaceutical-grade PEG 3350 is trusted for manufacturing and assay development.

5. Sinopharm Chemical Reagent Co., Ltd.

Overview:
As a leading Chinese chemical supplier, Sinopharm offers a broad spectrum of excipients and APIs, including PEG 3350.

Capabilities and Offerings:

  • Cost-competitive PEG 3350 supply
  • GMP and ISO certifications
  • Strong presence in Asian markets

Market Position:
Sinopharm’s strategic focus on Asia and competitive pricing make it a viable option for bulk procurement, especially in the emerging markets.

6. Spectrum Chemical Mfg. Corp.

Overview:
A U.S.-based supplier specializing in laboratory and pharmaceutical chemicals, Spectrum Chemical provides PEG 3350 to both research and manufacturing sectors.

Capabilities and Offerings:

  • Pharmaceutical and USP-grade PEG 3350
  • Certifications including NSF, ISO, and cGMP
  • Flexible supply chain for small and large volume orders

Market Position:
Spectrum’s agility and quality certification enable it to serve niche and bulk customers efficiently.


Emerging Markets and Regional Suppliers

In addition to established global giants, regional suppliers in China, India, and Southeast Asia have grown significantly, driven by manufacturing cost advantages and increasing local demand. Companies like Hubei Bailing Biological Technology and Banaji International are increasingly supplying PEG 3350, often targeting emerging markets with competitive pricing, though their GMP compliance varies and warrants thorough due diligence.


Quality and Regulatory Considerations

Selecting a PEG 3350 supplier necessitates rigorous evaluation of quality standards, including in-process controls, batch consistency, and compliance with pharmacopeial monographs—USP, EP, or JP. Due diligence should also encompass review of certificates of analysis (CoA), stability data, and supplier audits to ensure adherence to all applicable regulatory requirements.

An increasing emphasis on sustainability and supply chain transparency adds further dimensions to supplier evaluation—particularly in avoiding contamination risks and ensuring traceability.


Market Trends Influencing Supplier Selection

  • Consolidation of Suppliers: Larger chemical companies are acquiring regional players, leading to a more consolidated market with fewer but more reliable sources.
  • Regulatory Stringency: Stricter global regulations heighten the importance of GMP-certified suppliers.
  • Supply Chain Resilience: The COVID-19 pandemic underscored the necessity of diversified supply chains to mitigate disruptions.
  • Sustainability Practices: Buyers increasingly favor suppliers with environmentally responsible manufacturing processes.

Conclusion

The supply landscape for PEG 3350 is characterized by a mix of well-established multinational corporations and regional players. Top-tier suppliers like BASF, Dow, and Ashland provide high-quality, GMP-compliant PEG 3350, essential for pharmaceutical formulations requiring stringent regulatory adherence. Asian suppliers can offer cost advantages but demand careful vetting to ensure compliance.

Selecting the right supplier hinges on assessing manufacturing quality, regulatory compliance, supply stability, and cost considerations. Establishing robust quality agreements and conducting thorough supplier audits are prudent steps to safeguard supply chain integrity.

Key Takeaways

  • Leading global suppliers of PEG 3350 include BASF, Dow, Ashland, and Sigma-Aldrich, known for quality and compliance.
  • Regional suppliers in Asia can provide cost-effective options but require diligent due diligence.
  • Regulatory adherence to GMP standards, certificates of analysis, and traceability are critical in supplier selection.
  • Supply chain diversification and sustainability considerations are increasingly influencing procurement strategies.
  • Due to regulatory scrutiny, ongoing supplier audits and quality assurance are essential to mitigate risks.

FAQs

1. What qualities should I look for in a PEG 3350 supplier?
Key qualities include GMP compliance, batch-to-batch consistency, high purity levels, proper documentation (such as COA), and a reliable delivery history. Certifications like USP, EP, or JP monographs further affirm quality standards.

2. How does regional sourcing impact the quality and regulation of PEG 3350?
Regional suppliers may vary in regulatory adherence; hence, it is crucial to verify their GMP certification, quality controls, and ability to meet international standards to ensure product safety and efficacy.

3. Are there differences between pharmaceutical-grade PEG 3350 and laboratory-grade PEG?
Yes. Pharmaceutical-grade PEG 3350 complies with pharmacopoeial standards (USP, EP, JP), with stricter purity and impurity controls, making it suitable for medicinal use. Laboratory-grade PEG may not meet these standards and is generally suitable for research purposes.

4. What role does supply chain resilience play in sourcing PEG 3350?
Supply chain resilience minimizes risks of shortages or delays. Diversifying suppliers, including regionally located manufacturers, enhances security; establishing long-term agreements can also stabilize supply.

5. How do sustainability practices influence supplier selection?
Increasing regulatory and company focus on sustainability mandates evaluating suppliers’ environmental practices, including waste management, energy efficiency, and responsible sourcing to align with corporate social responsibility and reduce regulatory risks.


Sources:
[1] MarketWatch. “Polyethylene Glycol Market Analysis,” 2022.
[2] European Pharmacopoeia. PEG specifications.
[3] U.S. Pharmacopeia. PEG monographs.
[4] BASF Product Portfolio. Official website.
[5] Dow Chemical. PEG Product Data Sheets.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.